This inventor holds 18 USPTO granted patents, primarily in Antifungal Compounds. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Scynexis, Inc.. Active years: 1995-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
15 out of 4,770 
2 out of 2,405 
2 out of 19 
Years Active: 1995-2012
Areas of Expertise:
Title: The Innovations of Frances A. Bouffard in Antifungal Agents
Introduction
Frances A. Bouffard is an innovative inventor based in Scotch Plains, NJ, who has made significant contributions to the field of antifungal treatments. With a remarkable portfolio of 18 patents, her work focuses on developing novel compounds aimed at combating fungal infections and enhancing therapeutic options for patients.
Latest Patents
One of her latest patents introduces antifungal agents that feature novel derivatives of enfumafungin. This patent details their pharmaceutically acceptable salts, hydrates, and prodrugs. Frances's inventions encompass methods of preparing these compounds and their application as antifungal agents or inhibitors of (1,3)-β-D-glucan synthase. The compounds she has disclosed promise to be useful in treating and preventing fungal infections, along with various associated diseases and conditions. Another patent further explores enfumafungin derivatives, claiming their utility as inhibitors of (1,3)-β-D-glucan synthase, solidifying her role in advancing antifungal therapies.
Career Highlights
Frances A. Bouffard has had an illustrious career, working at reputable companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. Her experiences at these organizations have equipped her with the expertise necessary to innovate in the pharmaceutical sector, particularly in drug development and research.
Collaborations
Throughout her career, Frances has collaborated with numerous professionals, including her notable coworkers, James M. Balkovec and James Francis Dropinski. These collaborations have likely enriched her research perspectives and contributed to her successes in patent development.
Conclusion
Frances A. Bouffard stands out as a pivotal figure in the field of antifungal innovations. Her extensive patent portfolio and fruitful collaborations highlight her critical role in advancing the understanding and treatment of fungal infections. With her ongoing contributions, the potential for improved therapeutic options continues to grow, ensuring a positive impact on public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile